The Peritoneal Cancer Index is a medical scoring system used to measure how much cancer has spread throughout the peritoneum—the membrane lining the abdominal cavity. It helps doctors plan treatment and understand whether surgery can successfully remove the cancer.

Understanding Prognosis and Survival Expectations

The outlook for patients with cancer affecting the peritoneum depends heavily on how much disease is present, and the Peritoneal Cancer Index plays a key role in understanding this. When doctors calculate this index, they’re essentially mapping out where tumors are located and how large they’ve grown. Higher scores indicate more extensive disease spread, which generally means a more challenging situation for both patient and medical team.^[1]

For patients with ovarian cancer that has spread to the peritoneum, research shows that a PCI score (the numerical result from measuring tumor burden) above 13 is associated with worse survival outcomes. In one study involving 96 patients with advanced ovarian cancer, those with higher PCI scores faced greater challenges. The score acted as a predictor, helping doctors understand what to expect in terms of disease progression and response to treatment.^[4]

In cases of pseudomyxoma peritonei (a rare cancer that produces jelly-like material in the abdomen), the prognosis differs based on whether the disease is low-grade or high-grade. For low-grade disease, a PCI score of 21 or below generally indicates a better chance of complete surgical removal. For high-grade disease, this threshold is 25. When scores exceed these cutoff points, the likelihood of completely removing all visible cancer decreases significantly.^[3]

The most important factor affecting long-term survival is whether surgeons can achieve what’s called complete cytoreductive surgery—meaning they can remove all visible tumors. The Peritoneal Cancer Index helps predict this possibility before surgery even begins. When patients have very high scores, particularly above 33 in some cancers, only about 28% achieve complete tumor removal, which directly impacts how long they might live with their disease.^[9]

Natural Progression Without Treatment

When cancer spreads to the peritoneum and remains untreated, the disease typically continues to grow throughout the abdominal cavity. The peritoneum is like a large sheet that lines the inside of the abdomen and covers most organs housed there. Cancer cells can travel through the natural circulation of peritoneal fluid (the small amount of liquid normally present in this space), settling in areas where the fluid naturally collects or slows down.^[12]

These settling points aren’t random. Cancer tends to accumulate in specific regions: the space beneath the diaphragm (the muscle separating chest from abdomen), along the gutters on either side of the colon, around the pelvis, and near the small intestine. As the disease progresses, tumors can grow in these areas, sometimes becoming quite large. Some cancers create nodules—small lumps scattered across the peritoneal surface—while others cause thickening and infiltration of the fatty tissue.^[12]

Without intervention, the growing tumors can interfere with normal organ function. The intestines may become partially or completely blocked, making it difficult or impossible for food to pass through. Fluid tends to accumulate in the abdomen, a condition called ascites, causing the belly to swell and become uncomfortable. This happens because the cancer disrupts the normal balance of fluid production and absorption in the peritoneal space.^[5]

As the Peritoneal Cancer Index score rises—indicating more widespread disease—patients experience increasingly severe symptoms. The cancer continues spreading to involve more regions of the abdomen and the tumors within each region grow larger. Eventually, this progression affects quality of life significantly and shortens survival time. The speed of this progression varies depending on the type of original cancer and its biological behavior, but the trajectory is generally toward increasing disability and complications.^[9]

Possible Complications

Cancer affecting the peritoneum can lead to several serious complications that develop unexpectedly and require immediate medical attention. One of the most common problems is bowel obstruction, which happens when growing tumors press on or infiltrate the intestines, preventing food and waste from moving through normally. This can cause severe pain, vomiting, inability to pass gas or stool, and requires urgent care. In some cases, surgeons must create a stoma—an opening from the intestine to the outside of the body—to allow waste to exit when the normal pathway is blocked.^[16]

Fluid accumulation in the abdomen becomes increasingly problematic as disease progresses. When ascites develops, the belly can swell dramatically, causing not only discomfort but also difficulty breathing. The accumulated fluid pushes up against the diaphragm, reducing lung capacity and making even simple activities exhausting. Some patients need repeated procedures to drain this fluid, though it often returns within days or weeks.^[5]

The urinary system can also be affected when tumors grow near or around the tubes (ureters) that carry urine from the kidneys to the bladder. When these become blocked, urine backs up into the kidneys, potentially causing kidney damage or infection. Doctors may need to insert a tube called a nephrostomy directly into the kidney to drain urine to the outside of the body, or place a stent to keep the ureter open.^[16]

Higher Peritoneal Cancer Index scores indicate more extensive disease and therefore higher risk for these complications. Research shows that patients with PCI scores above 24 who undergo surgery experience increased rates of complications compared to those with lower scores. The surgical complications can include bleeding, infection, leaks from intestinal connections, and problems with wound healing.^[9]

Nutritional problems often develop because the disease and its complications interfere with eating and digestion. Nausea and vomiting may be persistent. The body’s metabolism changes when fighting cancer, and combined with reduced food intake, this can lead to significant weight loss and muscle wasting. This weakened state makes it harder to tolerate treatments and fight infections, creating a cycle that’s difficult to break.^[5]

Impact on Daily Life

Living with cancer in the peritoneum profoundly affects every aspect of daily existence, even before symptoms become severe. Physical activities that once seemed effortless—walking, climbing stairs, carrying groceries—can become exhausting challenges. The fatigue associated with this disease is different from ordinary tiredness; it’s a deep, overwhelming exhaustion that doesn’t improve with rest. This constant weariness makes it difficult to maintain normal routines, work schedules, or social commitments.^[5]

As the abdomen swells with fluid or growing tumors, physical comfort becomes elusive. Finding a comfortable position to sleep can be nearly impossible. Clothing no longer fits properly, which can be distressing and isolating. The visible changes to one’s body often affect self-image and confidence, making social interactions uncomfortable. Many patients withdraw from activities they once enjoyed because they feel self-conscious or physically unable to participate.^[5]

Digestive symptoms create particularly challenging situations. Persistent nausea can make mealtimes miserable rather than enjoyable. When eating causes discomfort or early fullness, sharing meals with family and friends—a fundamental social activity—becomes difficult. Constipation or bowel changes require frequent bathroom access and can make leaving home anxiety-provoking. These practical concerns often lead to social isolation, even when patients desperately want connection with others.

The emotional weight of knowing the Peritoneal Cancer Index score and understanding its implications can be overwhelming. Patients may experience anxiety, depression, fear about the future, and grief over losses already experienced and those anticipated. The psychological burden affects not just the patient but entire families. Children, partners, and parents struggle to understand and cope with the changing circumstances.

Work life often becomes impossible to maintain, particularly when the PCI score is high and treatment is intensive. The physical demands of most jobs exceed what patients can manage. Frequent medical appointments, procedures to drain fluid, or surgical interventions make regular attendance unrealistic. The financial impact of lost income combined with medical expenses creates additional stress that affects the entire household.

Simple daily tasks require new strategies. Bending, lifting, or reaching may cause pain or discomfort. Getting dressed, preparing meals, or basic housework may require assistance. This loss of independence can be one of the hardest adjustments, as it requires accepting help with intimate activities previously managed alone. Many patients describe feeling like a burden on their loved ones, even though family members gladly provide care.

Support for Families Regarding Clinical Trials

Family members play a crucial role in helping patients navigate the possibility of participating in clinical trials, especially when dealing with advanced cancer that has spread to the peritoneum. Understanding what clinical trials offer—and what they cannot promise—is the first step in providing meaningful support. Clinical trials test new approaches to treatment, including novel surgical techniques, different chemotherapy combinations, or innovative delivery methods for existing drugs. However, participation in a trial doesn’t guarantee better outcomes than standard treatment, and it’s important that both patients and families understand this from the beginning.^[5]

When a patient’s Peritoneal Cancer Index score suggests extensive disease, clinical trials may offer access to treatments not yet widely available. For instance, research is ongoing into improved methods of delivering heated chemotherapy directly into the abdominal cavity during surgery, or testing new drugs that target specific characteristics of peritoneal tumors. Families can help by researching which trials are available, what they involve, and whether the patient meets the eligibility requirements. Many trials have specific criteria regarding PCI scores, previous treatments, and overall health status.^[5]

Practical support makes an enormous difference in a patient’s ability to participate in trials. Research studies often require frequent hospital visits for monitoring, additional tests beyond standard care, and meticulous record-keeping. Family members can help by organizing transportation to appointments, keeping track of symptoms and side effects, ensuring medications are taken as prescribed, and maintaining a calendar of study-related obligations. This logistical support removes barriers that might otherwise prevent participation.

The emotional aspects of trial participation require family understanding and support. Patients may feel anxious about receiving experimental treatments or worried about potential side effects. They might experience disappointment if they’re assigned to a control group receiving standard treatment rather than the experimental approach. Conversely, they may feel hopeful that the trial offers their best chance. Family members help by listening without judgment, acknowledging these complex feelings, and reminding patients that their participation contributes valuable knowledge regardless of personal outcomes.

Families should understand that clinical trials involve informed consent—a detailed process where doctors explain the trial’s purpose, procedures, risks, benefits, and alternatives. Family members can attend these discussions, ask questions, and help patients think through the decision. It’s helpful to prepare questions in advance: What are the potential benefits and risks? What additional time commitment is required? Can the patient withdraw if they change their mind? What happens when the trial ends?

Financial considerations often arise with trial participation. While the experimental treatment itself is typically provided at no cost, other expenses—such as additional scans, laboratory tests, or travel to the research center—may not be covered. Families can help by investigating what their insurance will cover, whether the trial sponsor provides financial assistance, and what out-of-pocket costs to expect. This information helps patients make fully informed decisions.

It’s also important for families to recognize when a clinical trial may not be the right choice. If a patient’s PCI score is very high and their overall condition is weak, the demands of trial participation might reduce quality of life without offering meaningful benefit. In these situations, families can support the decision to focus on comfort care rather than pursuing every possible treatment option. Sometimes the most loving support means helping a patient choose peace over continued interventions.